EV/EBITDA
-8.44
-0.30-3.69%
Wed, 27 Nov 2024 22:31:06 GMT
Summary:
Akero Therapeutics EV/EBITDA is currently -8.44, with a fall of -0.30 (-3.69%) during the most recent trading day. Over the past year, it has dropped by -2.74 (-48.07%). AKRO EV/EBITDA is now -621.37% below its all-time high of -1.17.AKRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -3.7% |
| 1 m1 month | -11.5% |
| 3 m3 months | -9.0% |
| 6 m6 months | -118.1% |
| ytdytd | -14.2% |
| 1 y1 year | -48.1% |
| 5 y5 years | +31.8% |
AKRO EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -7.39 | -14.2% | -9.69 | +12.9% |
| 3 m | 3 months | -6.80 | -24.1% | -9.69 | +12.9% |
| 6 m | 6 months | -3.86 | -118.7% | -9.69 | +12.9% |
| 1 y | 1 year | -3.86 | -118.7% | -13.12 | +35.7% |
| 3 y | 3 years | -1.17 | -621.4% | -26.86 | +68.6% |
| 5 y | 5 years | -1.17 | -621.4% | -26.86 | +68.6% |
| alltime | all time | -1.17 | -621.4% | -38.76 | +78.2% |
Akero Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -8.44(+14.2%) |
| 2023 | -7.39(-64.7%) |
| 2022 | -20.92(+257.6%) |
| Date | Value |
|---|---|
| 2021 | -5.85(-34.0%) |
| 2020 | -8.87(-28.9%) |
| 2019 | -12.47 |
FAQ
- What is Akero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akero Therapeutics?
- What is AKRO EV/EBITDA year-to-date change?
- What is Akero Therapeutics EV/EBITDA year-on-year change?
What is Akero Therapeutics EV/EBITDA?
The current EV/EBITDA of AKRO is -8.44
What is the all time high EV/EBITDA for Akero Therapeutics?
Akero Therapeutics all-time high EV/EBITDA is -1.17
What is AKRO EV/EBITDA year-to-date change?
Akero Therapeutics EV/EBITDA has changed by -1.05 (-14.21%) since the beginning of the year
What is Akero Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKRO EV/EBITDA has changed by -2.74 (-48.07%)